About the Company
We do not have any company description for Cytosorbents Corp at the moment.
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & Apparatus
Employees
176
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Cytosorbents Corp
CytoSorbents Corporation – Trentonian
August 12, 2021 at 5:03 a.m. MONMOUTH JUNCTION, N.J., Aug. 12, 2021 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in intensive ...
7CTSO : Demystifying CytoSorbents: Insights From 5 Analyst Reviews
The standing of CytoSorbents among financial experts is revealed through an in-depth exploration of recent analyst actions.
CytoSorbents to Report Second Quarter 2025 Financial Results and Recent ...
CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, will report second ...
Cytosorbents Corp Q2 2025 Earnings Call Highlights
Cytosorbents Corp (($CTSO)) has held its Q2 earnings call. Read on for the main highlights of the call. Cytosorbents Corp’s recent earnings call ...
CytoSorbents receives $2M grant for ‘universal plasma ... - NJBIZ
The U.S. Army Medical Research Acquisition Activity awarded Princeton-based CytoSorbents Corp. a two-year, $1.98 million grant to further develop its HemoDefend-BGA adsorber, which – in short ...
CytoSorbents Corporation’s Q3 2024 Financial Highlights
In its latest earnings report for the third quarter of 2024, CytoSorbents Corporation reported a total revenue of $9.4 million, marking a 7% increase compared to the previous year.
Why CytoSorbents (CTSO) Stock Is Trading Higher
In the the case of CytoSorbents, which is trading at $0.84 as of publishing time, $100 would buy you 119.05 shares of stock. If you're looking to bet against a company, the process is more complex.
A Glimpse Into The Expert Outlook On CytoSorbents Through 5 ... - Nasdaq
Discovering CytoSorbents: A Closer Look CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology.
Cytosorbents Corporation (CTSO) Q1 2024 Earnings Call Transcript
Cytosorbents Corporation (NASDAQ: CTSO) Q1 2024 Earnings Conference Call May 9, 2024 4:30 PM ET Company Participants Eric Ribner - Investor Relations Phil Chan - Chief Executive Officer Vincent ...
CytoSorbents receives $740K from tax program - NJBIZ
CytoSorbents received approximately $740,000, net of transactions costs, in cash proceeds from the sale of its 2020 NOL and R&D credits.
Cytosorbents Corp hosts conference call for investors
Cytosorbents Corp stock is down 46.52% compared to the same time last year. Shares are trading at $1.02, and Wall Street analysts have a neutral overall rating of the company, with 2 of 3 analysts ...
When Will Cytosorbents Corporation (NASDAQ:CTSO) Turn A Profit?
We feel now is a pretty good time to analyse Cytosorbents Corporation's (NASDAQ:CTSO) business as it appears the company may be on the cusp of a considerable accomplishment. Cytosorbents ...
Similar Companies
Loading the latest forecasts...